Home > Financial Ratios > SEQUENT SCIENTIFIC

SEQUENT SCIENTIFIC
Core EBITDA Growth

    Back to All Ratios
SEQUENT SCIENTIFIC is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SEQUENT SCIENTIFIC
Please provide your vote to see the results

SEQUENT SCIENTIFIC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 143.86294.50-84.74-45.4522.18

What is the latest Core EBITDA Growth ratio of SEQUENT SCIENTIFIC ?

The latest Core EBITDA Growth ratio of SEQUENT SCIENTIFIC is 143.86 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025143.86
Mar2024294.50
Mar2023-84.74
Mar2022-45.45
Mar202122.18

How is Core EBITDA Growth of SEQUENT SCIENTIFIC Trending?

Years Core EBITDA Growth % Change
Mar2025 143.86
-51.15
Mar2024 294.5
Positive
Mar2023 -84.74
Negative
Mar2022 -45.45
Negative
Mar2021 22.18 -

Other Financial Ratios of SEQUENT SCIENTIFIC


Compare Core EBITDA Growth ratio of peers of SEQUENT SCIENTIFIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SEQUENT SCIENTIFIC ₹8,622.2 Cr -2% -2.1% 30.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,999.0 Cr 3.6% 7% 15.3% Stock Analytics
DIVIS LABORATORIES ₹169,139.0 Cr 1.1% 5.8% 14.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,791.0 Cr 1.9% 12.3% 49.2% Stock Analytics
DR REDDYS LABORATORIES ₹109,664.0 Cr 1.8% 5.9% 14.8% Stock Analytics
CIPLA ₹107,685.0 Cr 1.6% 0.2% -5.4% Stock Analytics


SEQUENT SCIENTIFIC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SEQUENT SCIENTIFIC

-2%

-2.1%

30.1%

SENSEX

-2.5%

-6.1%

7%


You may also like the below Video Courses